EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Network Pharmacology and Serum Nontargeted Metabolomics Reveal the Protective Effects of Propionate Against Liver Damage Induced by a High‐Fat and AGE‐Rich Diet in Diabetic Mice

Liang Wu iD, Jiajun Tan iD, Wen Sun, Xueyun Dong iD, Jiayuan He iD, Asmaa Ali iD, Min Chen, Leilei Zhang iD, Pingping Wang iD

Journal of Diabetes Research · 2025-01 · 2025 (1)

DOI: 10.1155/jdr/3955893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, online erschienen am 02.07.2025. Verfasst von Liang Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China. Hauptthemen laut MEDLINE: Diet, High-Fat, Liver, Propionates, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Social Development Project of Zhenjiang City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic liver injury is a leading cause of mortality in diabetes, with no specific treatment available. Sodium propionate (NaP) has anti‐inflammatory and antioxidant properties, but its effectiveness in treating diabetic liver injury is still lacking research. The study employed network pharmacology to identify potential targets of NaP for Type 2 diabetes treatment, using oleic acid (OA) and advanced glycation end products (AGEs) to induce diabetic liver injury in HepG2 cells in vitro . Post‐NaP intervention, Oil Red O staining assessed cellular lipid deposition, while Western blotting analyzed protein expression associated with oxidative stress, autophagy, and bile acid synthesis. NaP was administered to mice with diabetic liver injury induced by a high‐fat and AGEs diet, and qPCR analysis was conducted to assess the expression of genes associated with inflammation, oxidative stress, and bile acid synthesis in the liver. HE staining was used to observe the liver injury, and nontargeted metabolomics analysis was used to analyze the effect of NaP on serum metabolic pathways. Network pharmacology analysis showed that NaP has anti‐inflammatory and antioxidant effects, mainly involving multiple targets such as mitochondrial function, insulin resistance, and glucose metabolism. Experimental results in cells and animals demonstrated that NaP reduces lipid accumulation and inflammation in liver cells; decreases inflammatory markers like NLRP3, IL‐1 β , and TNF‐ α ; enhances antioxidant factors such as serum SOD and liver Nrf2; increases the expression of the bile acid synthesis enzyme CYP7A1; and upregulates autophagy in liver cells. Serum nontargeted metabolomics indicated that NaP enhances anti‐inflammatory and antioxidant metabolites, including proline and N‐Acetyl‐L‐leucine, in diabetic liver injury mice. It potentially influences purine metabolism, amino acid synthesis (e.g., arginine, tryptophan, and tyrosine), and steroid hormone biosynthesis. This study indicates that NaP may serve as a preventive and therapeutic agent for diabetic liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatLiverPropionatesDiabetes Mellitus, ExperimentalAnti-Inflammatory AgentsLiver DiseasesAnimalsMetabolomicsHumansMiceOxidative StressNetwork PharmacologyHep G2 CellsMaleGlycation End Products, AdvancedMice, Inbred C57BLAntioxidants

Stichwörter der Autor:innen

autophagydiabetic liver injurynetwork pharmacologynontargeted metabolomicspropionate

Substanzen

Glycation End Products, AdvancedPropionatesAntioxidantsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
  • Department of Laboratory Medicine, Taizhou Second People's Hospital, Taizhou, China.
  • Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, China.
  • Health Testing Center, Zhenjiang Center for Disease Control and Prevention, Zhenjiang, China.
  • Department of Pulmonary Medicine, Abbassia Chest Hospital, EMOH, Cairo, Egypt.
  • Public Experiment and Service Center, Jiangsu University, Zhenjiang, China.

ORCID-Profile: Liang Wu, Jiajun Tan, Xueyun Dong, Jiayuan He, Asmaa Ali, Leilei Zhang, Pingping Wang

Förderung

  • Science and Technology Planning Social Development Project of Zhenjiang City

Zitieren

APA

Wu, L., Tan, J., Sun, W., Dong, X., He, J., Ali, A., Chen, M., Zhang, L., & Wang, P. (2025). Network Pharmacology and Serum Nontargeted Metabolomics Reveal the Protective Effects of Propionate Against Liver Damage Induced by a High‐Fat and AGE‐Rich Diet in Diabetic Mice. Journal of Diabetes Research, 2025(1). https://doi.org/10.1155/jdr/3955893

Vancouver

Wu L, Tan J, Sun W, Dong X, He J, Ali A, et al. Network Pharmacology and Serum Nontargeted Metabolomics Reveal the Protective Effects of Propionate Against Liver Damage Induced by a High‐Fat and AGE‐Rich Diet in Diabetic Mice. Journal of Diabetes Research. 2025;2025(1). doi:10.1155/jdr/3955893

BibTeX
@article{Wu2025,
  author = {Wu, Liang and Tan, Jiajun and Sun, Wen and Dong, Xueyun and He, Jiayuan and Ali, Asmaa and Chen, Min and Zhang, Leilei and Wang, Pingping},
  title = {Network Pharmacology and Serum Nontargeted Metabolomics Reveal the Protective Effects of Propionate Against Liver Damage Induced by a High‐Fat and AGE‐Rich Diet in Diabetic Mice},
  journal = {Journal of Diabetes Research},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/jdr/3955893}
}
Kostenlos starten →